Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Flow Chemistry Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105906656A reveals flow chemistry route for crizotinib intermediate. Reduces cost and energy significantly. Reliable supplier for pharmaceutical intermediates ensuring high purity.
Patent CN108658871B details a continuous flow method for 4, 6-dichloro-5-methoxypyrimidine, offering high purity and reduced costs for API manufacturing.
Eliminate metal catalysts and inert gas requirements in quinoline synthesis. Our CDMO expertise ensures scalable, green production for antimalarial drugs and PDE4 inhibitors.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.